Daniel Hume Tg Therapeutics, Inc. (TGTX) insider trading activity

TGTX Quotes by TradingView

Daniel Hume is Director of TG THERAPEUTICS, INC.. Currently has a direct ownership of 192,748 shares of TGTX, which is worth approximately $6.94 Million. The most recent transaction as insider was on Jun 12, 2025, when has been sold 14,718 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 193K
8.27% 3M change
19.85% 12M change
Total Value Held $6.94 Million

DANIEL HUME Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2025
BUY
Grant, award, or other acquisition
-
14,718 Added 7.09%
192,748 Common Stock
Mar 17 2025
SELL
Bona fide gift
-
62,459 Reduced 25.97%
178,030 Common Stock
Jun 19 2024
BUY
Grant, award, or other acquisition
-
22,250 Added 8.47%
240,489 Common Stock
Sep 28 2023
BUY
Grant, award, or other acquisition
-
20,000 Added 8.39%
218,239 Common Stock
Jul 20 2022
BUY
Grant, award, or other acquisition
-
43,732 Added 18.07%
198,239 Common Stock
Jun 18 2021
BUY
Grant, award, or other acquisition
-
20,000 Added 11.46%
154,507 Common Stock

Also insider at

NHLD
NATIONAL HOLDINGS CORP
Director
DH

Daniel Hume

Director
New York, NY

Track Institutional and Insider Activities on TGTX

Follow TG THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TGTX shares.

Notify only if

Insider Trading

Get notified when an Tg Therapeutics, Inc. insider buys or sells TGTX shares.

Notify only if

News

Receive news related to TG THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TGTX